Argentum Pharmaceuticals LLC v. Merck Patentgesellschaft Mit Beschrankter Haftung > Summary
Court Case Number IPR2018-00423
Filing Date Jan 5, 2018
Court Patent Trial and Appeal Board
Status Terminated-Denied
Administrative JudgesRichard James Smith, Robert A. Pollock, Den Serna
Judge Writing the Final DecisionRichard James Smith
Claims Challenged in the Petition: 1, 11, 12, 14, 15
Petitioner
Patent Owner
Petitioner Attorneys
6Argentum Pharmaceuticals
Attorney Name: Karla I. Arias
Crowell & Moring
Argentum Pharmaceuticals
Attorney Name: Deborah H. Yellin
Crowell & Moring
Argentum Pharmaceuticals
Attorney Name: Tyler C. Liu
Argentum Pharmaceuticals
Argentum Pharmaceuticals
Attorney Name: Teresa Stanek Rea
Crowell & Moring
Argentum Pharmaceuticals
Attorney Name: Sanjay Mathew
Crowell & Moring
Argentum Pharmaceuticals
Attorney Name: Robin D. Rogers
Crowell & Moring
Patent Owner Attorneys
4Merck Patentgesellschaft
Attorney Name: Deric X. Geng
Wilmer Cutler Pickering Hale and Dorr
Attorney Name: Vinita Ferrera
Wilmer Cutler Pickering Hale and Dorr
Attorney Name: David B. Bassett
Wilmer Cutler Pickering Hale and Dorr
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08673921 | Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride | Mar 18, 2014 |
